Elutia to Participate in Upcoming Investor Conferences
Elutia (Nasdaq: ELUT), a drug-eluting biomatrix technologies company, has announced its participation in three upcoming investor conferences in New York this September.
The company's leadership, including CEO Dr. Randy Mills and CFO Matt Ferguson, will attend the Cantor Global Healthcare Conference (Sept. 4), the H.C. Wainwright Global Investment Conference (Sept. 10), and the Lake Street Capital Markets Best Ideas Growth Conference (Sept. 11). The first two events will feature fireside chats and presentations, while the Lake Street conference will focus on one-on-one meetings.
Elutia (Nasdaq: ELUT), azienda specializzata in biomatrici a rilascio farmacologico, ha comunicato la propria partecipazione a tre conferenze per investitori a New York previste per questo settembre.
La dirigenza, tra cui il CEO Dr. Randy Mills e il CFO Matt Ferguson, sarà presente al Cantor Global Healthcare Conference (4 settembre), al H.C. Wainwright Global Investment Conference (10 settembre) e al Lake Street Capital Markets Best Ideas Growth Conference (11 settembre). I primi due eventi prevedono fireside chat e presentazioni, mentre la conferenza di Lake Street sarà incentrata su incontri individuali.
Elutia (Nasdaq: ELUT), compañía de tecnologías de biomatrices con liberación de fármacos, ha anunciado su participación en tres conferencias para inversores en Nueva York este septiembre.
La dirección, incluidos el CEO Dr. Randy Mills y el CFO Matt Ferguson, asistirá al Cantor Global Healthcare Conference (4 de septiembre), al H.C. Wainwright Global Investment Conference (10 de septiembre) y al Lake Street Capital Markets Best Ideas Growth Conference (11 de septiembre). Los dos primeros eventos incluirán charlas informales y presentaciones, mientras que la cita de Lake Street se centrará en reuniones uno a uno.
Elutia (Nasdaq: ELUT), 약물 방출 바이오매트릭스 기술 기업이 이번 9월 뉴욕에서 열리는 세 건의 투자자 컨퍼런스에 참가한다고 발표했습니다.
CEO Dr. Randy Mills와 CFO Matt Ferguson를 포함한 경영진이 Cantor Global Healthcare Conference (9월 4일), H.C. Wainwright Global Investment Conference (9월 10일), Lake Street Capital Markets Best Ideas Growth Conference (9월 11일)에 참석합니다. 처음 두 행사는 파이어사이드 채트와 발표를 포함하고, Lake Street 컨퍼런스는 일대일 미팅에 중점을 둡니다.
Elutia (Nasdaq: ELUT), société spécialisée dans les biomatrices à libération de médicaments, a annoncé sa participation à trois conférences investisseurs à New York en septembre.
La direction, notamment le CEO Dr. Randy Mills et le CFO Matt Ferguson, assistera au Cantor Global Healthcare Conference (4 septembre), au H.C. Wainwright Global Investment Conference (10 septembre) et au Lake Street Capital Markets Best Ideas Growth Conference (11 septembre). Les deux premiers événements proposeront des talks et des présentations, tandis que la conférence Lake Street sera consacrée à des rendez‑vous individuels.
Elutia (Nasdaq: ELUT), ein Unternehmen für drug-eluting Biomatrix-Technologien, hat seine Teilnahme an drei Investorenkonferenzen im September in New York angekündigt.
Die Unternehmensleitung, darunter CEO Dr. Randy Mills und CFO Matt Ferguson, wird am Cantor Global Healthcare Conference (4. Sept.), am H.C. Wainwright Global Investment Conference (10. Sept.) und am Lake Street Capital Markets Best Ideas Growth Conference (11. Sept.) teilnehmen. Die ersten beiden Veranstaltungen umfassen Fireside-Chats und Präsentationen, während die Lake Street-Konferenz auf Einzelgespräche ausgelegt ist.
- None.
- None.
GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences in New York:
Cantor Global Healthcare Conference
Format: Fireside Chat and 1x1 Meetings
Fireside Chat Date and Time: Thursday, September 4, 2025, 9:45 a.m. ET
Webcast Link: Click Here
H.C. Wainwright 27th Annual Global Investment Conference
Format: Presentation and 1x1 Meetings
Presentation Date and Time: Wednesday, September 10, 2025, 9:30 a.m. ET
Webcast Link: Click Here
Lake Street Capital Markets 9th Annual Best Ideas Growth Conference
Format: 1x1 Meetings
Date: Thursday, September 11, 2025
Institutional investors interested in scheduling a meeting may contact their Cantor, H.C. Wainwright, or Lake Street representative or email IR@elutia.com.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.
FAQ
When is Elutia (ELUT) presenting at the Cantor Global Healthcare Conference 2025?
Who will represent Elutia at the upcoming investor conferences?
What type of presentation will Elutia give at the H.C. Wainwright Conference?
How can investors schedule meetings with Elutia management?
